Depletion of CD8+ T cells, but not CD4+ T cells, with antibodies abrogated the antitumor effect of UA (Figure 7I–K), suggesting that the UA‐enhanced anti‐tumor response is CD8+ T cell‐dependent. The gene discussed is CD8A; the disease is neoplasm.